MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takasaki, J.
Right arrow Articles by Furuichi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takasaki, J.
Right arrow Articles by Furuichi, K.

Vol. 60, Issue 3, 432-439, September 2001

ACCELERATED COMMUNICATION
Molecular Cloning of the Platelet P2TAC ADP Receptor: Pharmacological Comparison with Another ADP Receptor, the P2Y1 Receptor

Jun Takasaki, Masazumi Kamohara, Tetsu Saito, Mitsuyuki Matsumoto, Shun-ichiro Matsumoto, Takahide Ohishi, Takatoshi Soga, Hitoshi Matsushime, and Kiyoshi Furuichi

Molecular Medicine Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., Ibaraki, Japan

Platelet activation plays an essential role in thrombosis. ADP-induced platelet aggregation is mediated by two distinct G protein-coupled ADP receptors, Gq-linked P2Y1, and Gi-linked P2TAC, which has not been cloned. The cDNA encoding a novel G protein-coupled receptor, termed HORK3, was isolated. The HORK3 gene and P2Y1 gene were mapped to chromosome 3q21-q25. HORK3, when transfected in the rat glioma cell subline (C6-15), responded to 2-methylthio-ADP (2MeSADP) (EC50 = 0.08 nM) and ADP (EC50 = 42 nM) with inhibition of forskolin-stimulated cAMP accumulation. 2MeSADP (EC50 = 1.3 nM) and ADP (EC50 = 18 nM) also induced intracellular calcium mobilization in P2Y1-expressing cells. These results show that HORK3 is a Gi/o-coupled receptor and that its natural ligand is ADP. AR-C69931 MX and 2MeSAMP, P2TAC antagonists, selectively inhibited 2MeSADP-induced adenylyl cyclase inhibition in HORK3-expressing cells. On the other hand, A3P5PS, a P2Y1 antagonist, blocked only 2MeSADP-induced calcium mobilization in P2Y1-expressing cells. HORK3 mRNA was detected in human platelets and the expression level of HORK3 was equivalent to that of P2Y1. These observations indicate that HORK3 has the characteristics of the proposed P2TAC receptor. We have also determined that [3H]2MeSADP binds to cloned HORK3 and P2Y1. Competition binding experiments revealed a similarity in the rank orders of potency of agonists and the selectivity of antagonists as obtained in the functional assay. These results support the view that P2Y1 functions as a high-affinity ADP receptor and P2TAC as a low-affinity ADP receptor in platelets.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. I. Masyuk, S. A. Gradilone, J. M. Banales, B. Q. Huang, T. V. Masyuk, S.-O. Lee, P. L. Splinter, A. J. Stroope, and N. F. LaRusso
Cholangiocyte primary cilia are chemosensory organelles that detect biliary nucleotides via P2Y12 purinergic receptors
Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G725 - G734.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Yamazaki, M. Aoyama, S. Ohya, K. Muraki, K. Asai, and Y. Imaizumi
Novel Functions of Small Conductance Ca2+-activated K+ Channel in Enhanced Cell Proliferation by ATP in Brain Endothelial Cells
J. Biol. Chem., December 15, 2006; 281(50): 38430 - 38439.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. P. Abbracchio, G. Burnstock, J.-M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson, et al.
International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy
Pharmacol. Rev., September 1, 2006; 58(3): 281 - 341.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. J. Mundell, M. L. Jones, A. R. Hardy, J. F. Barton, S. M. Beaucourt, P. B. Conley, and A. W. Poole
Distinct Roles for Protein Kinase C Isoforms in Regulating Platelet Purinergic Receptor Function
Mol. Pharmacol., September 1, 2006; 70(3): 1132 - 1142.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. R. Hardy, P. B. Conley, J. Luo, J. L. Benovic, A. W. Poole, and S. J. Mundell
P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms
Blood, May 1, 2005; 105(9): 3552 - 3560.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Feng, A. G. Mery, E. M. Beller, C. Favot, and J. A. Boyce
Adenine Nucleotides Inhibit Cytokine Generation by Human Mast Cells through a Gs-Coupled Receptor
J. Immunol., December 15, 2004; 173(12): 7539 - 7547.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Takasaki, T. Saito, M. Taniguchi, T. Kawasaki, Y. Moritani, K. Hayashi, and M. Kobori
A Novel G{alpha}q/11-selective Inhibitor
J. Biol. Chem., November 12, 2004; 279(46): 47438 - 47445.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. J. Ennion, A. D. Powell, and E. P. Seward
Identification of the P2Y12 Receptor in Nucleotide Inhibition of Exocytosis from Bovine Chromaffin Cells
Mol. Pharmacol., September 1, 2004; 66(3): 601 - 611.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. F. Jarvis, B. Bianchi, J. T. Uchic, J. Cartmell, C.-H. Lee, M. Williams, and C. Faltynek
[3H]A-317491, a Novel High-Affinity Non-Nucleotide Antagonist That Specifically Labels Human P2X2/3 and P2X3 Receptors
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 407 - 416.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. L. Herold, A.-D. Qi, T. K. Harden, and R. A. Nicholas
Agonist Versus Antagonist Action of ATP at the P2Y4 Receptor Is Determined by the Second Extracellular Loop
J. Biol. Chem., March 19, 2004; 279(12): 11456 - 11464.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. T. Bodor, G. L. Waldo, S. B. Hooks, J. Corbitt, J. L. Boyer, and T. K. Harden
Purification and Functional Reconstitution of the Human P2Y12 Receptor
Mol. Pharmacol., November 1, 2003; 64(5): 1210 - 1216.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
F. Marteau, E. Le Poul, D. Communi, D. Communi, C. Labouret, P. Savi, J.-M. Boeynaems, and N. S. Gonzalez
Pharmacological Characterization of the Human P2Y13 Receptor
Mol. Pharmacol., July 1, 2003; 64(1): 104 - 112.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. V. Birk, E. Leno, H. D. Robertson, V. M. Bolotina, and H. H. Szeto
Interaction between ATP and catecholamines in stimulation of platelet aggregation
Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H619 - H625.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. B. Kulick and I. von Kugelgen
P2Y-Receptors Mediating an Inhibition of the Evoked Entry of Calcium through N-Type Calcium Channels at Neuronal Processes
J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 520 - 526.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Simon, A. K. Filippov, S. Goransson, Y. H. Wong, C. Frelin, A. D. Michel, D. A. Brown, and E. A. Barnard
Characterization and Channel Coupling of the P2Y12 Nucleotide Receptor of Brain Capillary Endothelial Cells
J. Biol. Chem., August 23, 2002; 277(35): 31390 - 31400.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. A. Nicholas
Identification of the P2Y12 Receptor: A Novel Member of the P2Y Family of Receptors Activated by Extracellular Nucleotides
Mol. Pharmacol., September 1, 2001; 60(3): 416 - 420.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics